- January 31, 2022
Two New Haven Locations Use Yale’s SalivaDirect COVID-19 Test
- January 27, 2022Source: The New Haven Register
New partnership between CT, Yale to expand saliva-based COVID testing at 2 New Haven locations
- November 02, 2021Source: YaleNews
FDA Authorizes Sample Pooling for Yale-developed SalivaDirect COVID Test
- August 26, 2020
Sex Differences in COVID-19 Immune Responses Affect Patient Outcomes
- August 15, 2020Source: YaleNews
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
- June 22, 2020Source: YaleNews
Yale and NBA Partner to Study Efficacy of New COVID-19 Test
Welcome
Our research focuses on the mechanisms driving the observed epidemiological patterns of respiratory infections, particularly pneumococcal disease and RSV. Pneumococcus causes a large burden of disease worldwide, particularly among young children and the elderly.
Major research questions in the lab are related to long-term bacterial evolution, impacts of immunization on carriage and disease in different populations, and seasonal determinants of bacterial disease incidence (including viral co-infections and carriage). These projects utilize both quantitative tools and experimental laboratory studies.
You can learn more about our research and recent publications here.